Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 2/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28613788 | 0.78 | CYP1A2 (0.34) | CYP1A2CYP2A6TYMSKDM4EALDH1A1 | |
| SCHEMBL28612147 | 0.76 | ALDH1A1 (0.39) | CYP1A2CYP2A6ALDH1A1HSD17B10LMNA | |
| SCHEMBL28615978 | 0.74 | ALDH1A1 (0.38) | KDM4EALDH1A1HSD17B10LMNAGAA | |
| SCHEMBL1226389 | 0.70 | P2RX7 (0.41) | KDM4EALDH1A1HSD17B10LMNAHPGD | |
| SCHEMBL1375296 | 0.69 | BRD4 (0.41) | CYP1A2CYP2A6KDM4EALDH1A1HSD17B10 | |
| SCHEMBL29702303 | 0.69 | BRD4 (0.41) | CYP1A2CYP2A6KDM4EALDH1A1HSD17B10 | |
| SCHEMBL21835397 | 0.69 | MEN1 (0.33) | CYP1A2CYP2A6TYMSKDM4EALDH1A1 | |
| SCHEMBL29443524 | 0.69 | MEN1 (0.33) | CYP1A2CYP2A6TYMSKDM4EALDH1A1 | |
| SCHEMBL21835493 | 0.67 | NPBWR1 (0.35) | CYP1A2CYP2A6TYMSALDH1A1LMNA | |
| SCHEMBL8340628 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12435044-B2 | Pyridazinone herbicides and pyridazinone intermediates used to prepare a herbicide | FMC CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |
| CN-119039233-A | Pyridazinone herbicides and pyridazinone intermediates for preparing the same | FMC公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-118994028-A | Pyridazinone herbicides and pyridazinone intermediates for preparing the same | FMC公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-113166075-B | Pyridazinone herbicides and pyridazinone intermediates for preparing the same | FMC公司 | 2024-10-25 | — | — | CN | disclosed |
| US-20220041560-A1 | PYRIDAZINONE HERBICIDES AND PYRIDAZINONE INTERMEDIATES USED TO PREPARE A HERBICIDE | FMC CORPORATION | 2022-02-10 | — | — | US | disclosed |
| CN-113166075-A | Pyridazinone herbicides and pyridazinone intermediates for the preparation thereof | FMC公司 | 2021-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435044-B2 | Pyridazinone herbicides and pyridazinone intermediates used to prepare a herbicide | CBR3, CBR1, CYP4F3 | CYP1A2 31/4885CYP2A6 51/4885TYMS 1449/4885 |
| US-20220041560-A1 | PYRIDAZINONE HERBICIDES AND PYRIDAZINONE INTERMEDIATES USED TO PREPARE A HERBICIDE | CBR3, CBR1, CYP4F3 | CYP1A2 31/4885CYP2A6 51/4885TYMS 1449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.